Cargando…
Noninvasive Prenatal Diagnosis Significance of ERG Methylation as a Biomarker in Down’s Syndrome
BACKGROUND: Down’s syndrome (DS) is a genetic disease with chromosome abnormality due to the increasing chromosome 21. This study focused on the clinical application value of ERG methylation level in blood of pregnant women as a biomarker in Down’s syndrome. MATERIAL/METHODS: The sham group consiste...
Autores principales: | Liu, Xiangju, Xue, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282964/ https://www.ncbi.nlm.nih.gov/pubmed/28111453 http://dx.doi.org/10.12659/MSM.898687 |
Ejemplares similares
-
Differentially Expressed MicroRNAs in Maternal Plasma for the Noninvasive Prenatal Diagnosis of Down Syndrome (Trisomy 21)
por: Kamhieh-Milz, Julian, et al.
Publicado: (2014) -
Attitudes of Filipino parents of children with Down syndrome on noninvasive prenatal testing
por: de Castro-Hamoy, Leniza G., et al.
Publicado: (2022) -
Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome
por: Xiao, Gefei, et al.
Publicado: (2022) -
The significance of trisomy 7 mosaicism in noninvasive prenatal screening
por: Qi, Yiming, et al.
Publicado: (2019) -
A case of prenatal diagnosis of 18p deletion syndrome following noninvasive prenatal testing
por: Zhao, Ganye, et al.
Publicado: (2019)